Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Filomia

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Intervirology|July 19, 2014
Therapy of occult hepatitis B virus infection and prevention of reactivationGiovanni Raimondo, Roberto Filomia, Sergio Maimone
Seminars in Immunopathology|July 26, 2012
Occult HBV infectionGiovanni Raimondo, Gaia Caccamo, Roberto Filomia, et al.
Medicine|September 4, 2015
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular CarcinomaSergio Maimone, Roberto Filomia, Carlo Saitta, et al.
British Journal of Clinical Pharmacology|January 26, 2017
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case seriesFrancesco Borgia, Irene Cacciola, Roberto Filomia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2017
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern ItalyTindaro Lembo, Francesca Saffioti, Benito Chiofalo, et al.
Clinics and Research in Hepatology and Gastroenterology|March 5, 2025
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapyMaria Stella Franzè, Carlo Saitta, Daniele Lombardo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosisIrene Cacciola, Roberto Filomia, Angela Alibrandi, et al.
Journal of Clinical Medicine|July 14, 2023
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of PregnancyRoberta Granese, Gloria Calagna, Angela Alibrandi, et al.
Digestive Diseases and Sciences|December 19, 2018
Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS)Sergio Maimone, Francesca Saffioti, Roberto Filomia, et al.
Journal of Personalized Medicine|December 29, 2022
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV ClearanceMaria Stella Franzè, Roberto Filomia, Gaia Caccamo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Intervirology|July 19, 2014
Therapy of occult hepatitis B virus infection and prevention of reactivationGiovanni Raimondo, Roberto Filomia, Sergio Maimone
Seminars in Immunopathology|July 26, 2012
Occult HBV infectionGiovanni Raimondo, Gaia Caccamo, Roberto Filomia, et al.
Medicine|September 4, 2015
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular CarcinomaSergio Maimone, Roberto Filomia, Carlo Saitta, et al.
British Journal of Clinical Pharmacology|January 26, 2017
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case seriesFrancesco Borgia, Irene Cacciola, Roberto Filomia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2017
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern ItalyTindaro Lembo, Francesca Saffioti, Benito Chiofalo, et al.
Clinics and Research in Hepatology and Gastroenterology|March 5, 2025
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapyMaria Stella Franzè, Carlo Saitta, Daniele Lombardo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosisIrene Cacciola, Roberto Filomia, Angela Alibrandi, et al.
Journal of Clinical Medicine|July 14, 2023
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of PregnancyRoberta Granese, Gloria Calagna, Angela Alibrandi, et al.
Digestive Diseases and Sciences|December 19, 2018
Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS)Sergio Maimone, Francesca Saffioti, Roberto Filomia, et al.
Journal of Personalized Medicine|December 29, 2022
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV ClearanceMaria Stella Franzè, Roberto Filomia, Gaia Caccamo, et al.
Pageof 3